These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A Case of Unilateral Hypnic Headache: Rapid Response to Ramelteon, a Selective Melatonin MT1/MT2 Receptor Agonist. Arai M Headache; 2015; 55(7):1010-1. PubMed ID: 26121162 [No Abstract] [Full Text] [Related]
4. Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect. Mini L; Wang-Weigand S; Zhang J Clin Ther; 2008 Jul; 30(7):1316-23. PubMed ID: 18691991 [TBL] [Abstract][Full Text] [Related]
5. Ramelteon: TAK 375. Drugs R D; 2005; 6(3):186-8. PubMed ID: 15869323 [TBL] [Abstract][Full Text] [Related]
6. Autoimmune hepatitis in association with ramelteon. Fourman LT; Robert Meyer B J Clin Gastroenterol; 2013 Aug; 47(7):651-4. PubMed ID: 23632362 [TBL] [Abstract][Full Text] [Related]
7. Ramelteon: a melatonin receptor agonist for the treatment of insomnia. Devi V; Shankar PK J Postgrad Med; 2008; 54(1):45-8. PubMed ID: 18296808 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy. Spadoni G; Bedini A; Lucarini S; Mor M; Rivara S Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1145-56. PubMed ID: 25956235 [TBL] [Abstract][Full Text] [Related]
16. Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders. Miyamoto M CNS Neurosci Ther; 2009; 15(1):32-51. PubMed ID: 19228178 [TBL] [Abstract][Full Text] [Related]
17. Melatonin receptors mediate improvements of survival in a model of polymicrobial sepsis. Fink T; Glas M; Wolf A; Kleber A; Reus E; Wolff M; Kiefer D; Wolf B; Rensing H; Volk T; Mathes AM Crit Care Med; 2014 Jan; 42(1):e22-31. PubMed ID: 24145838 [TBL] [Abstract][Full Text] [Related]
18. Ramelteon: a review of its use in insomnia. Simpson D; Curran MP Drugs; 2008; 68(13):1901-19. PubMed ID: 18729542 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of M-II, the major human metabolite of ramelteon. Nishiyama K; Nishikawa H; Kato K; Miyamoto M; Tsukamoto T; Hirai K Pharmacology; 2014; 93(3-4):197-201. PubMed ID: 24923230 [TBL] [Abstract][Full Text] [Related]
20. Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment. Roth T; Stubbs C; Walsh JK Sleep; 2005 Mar; 28(3):303-7. PubMed ID: 16173650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]